1. Guidance for industry: extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), September 1997.
2. Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1) Draft XXIII, European Medicines Agency, 2013.
3. Draft guideline on quality of oral modified release products, European Medicines Agency, 2012.
4. Skelly J, Amidon G, Barr W, Benet L, Carter F, Robinson J, et al. Testing and correlation for oral controlled/modified-release dosage forms. Pharm Res. 1990;7(9):975–82.
5. Cardot JM, Beyssac E. In vitro/in vivo correlations: scientific implications and standardisation. Eur J Drug Metab Pharmacokinet. 1993;18(1):113–20.